{"transactions":[{"id":2026756,"issuer":{"id":7625,"kind":"organization","name":"Cytosorbents Corp","symbol":"CTSO"},"owners":[{"id":117149,"kind":"person","name":"Kraus Al","position":1,"cik":"0001368152","reported_name":"Kraus Al","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-02-08T11:03:33.000Z","date":"2023-02-06","kind":"exercise","acquired":false,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options were granted to the reporting person on February 6, 2013 and were exercisable on the date of grant."}],"balance_after":0,"derivative":{"exercise_price":2.65,"expiration_date":"2023-02-06","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001104659-23-012103","document":"tm235846-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1175151/000110465923012103/tm235846-1_4seq1.xml","form_type":"4"}},{"id":2026755,"issuer":{"id":7625,"kind":"organization","name":"Cytosorbents Corp","symbol":"CTSO"},"owners":[{"id":117149,"kind":"person","name":"Kraus Al","position":1,"cik":"0001368152","reported_name":"Kraus Al","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-02-08T11:03:33.000Z","date":"2023-02-06","kind":"exercise","acquired":true,"shares":12000,"price":2.65,"value":31800.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes: (i) the following RSUs that will be settled into common stock upon vesting upon a \"Change In Control\" of CytoSorbents Corporation (the \"Company\") as defined in the Amended and Restated CytoSorbents Corporation 2014 Long-Term Incentive Plan: (a) 55,000 RSUs granted on April 8, 2015, (b) 5,000 RSUs granted on June 7, 2016, (c) 6,000 RSUs granted on February 24, 2017 and (d) 3,300 RSUs granted on March 15, 2018; and (ii) 72,746 shares of common stock owned by the reporting person."}],"balance_after":142046,"source":{"system":"sec-edgar","filing":"0001104659-23-012103","document":"tm235846-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175151/000110465923012103/tm235846-1_4seq1.xml","form_type":"4"}},{"id":2187174,"issuer":{"id":7625,"kind":"organization","name":"Cytosorbents Corp","symbol":"CTSO"},"owners":[{"id":117149,"kind":"person","name":"Kraus Al","position":1,"cik":"0001368152","reported_name":"Kraus Al","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-08-12T22:50:53.000Z","date":"2022-08-10","kind":"grant","acquired":true,"shares":37950,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options were granted pursuant to the Plan. The shares underlying the stock options will vest in four equal parts on 8/10/2022, 9/30/2022, 12/31/2022 and 3/31/2023, subject to the reporting person's continued service as of the applicable vesting date."}],"balance_after":37950,"derivative":{"exercise_price":1.95,"expiration_date":"2032-08-10","underlying":"Common Stock","underlying_shares":37950},"source":{"system":"sec-edgar","filing":"0001104659-22-090257","document":"tm2223355-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1175151/000110465922090257/tm2223355-6_4seq1.xml","form_type":"4"}},{"id":2278060,"issuer":{"id":7625,"kind":"organization","name":"Cytosorbents Corp","symbol":"CTSO"},"owners":[{"id":117149,"kind":"person","name":"Kraus Al","position":1,"cik":"0001368152","reported_name":"Kraus Al","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-09T20:13:29.000Z","date":"2022-05-06","kind":"purchase","acquired":true,"shares":5000,"price":1.959,"value":9795.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes: (i) the following RSUs that will be settled into common stock upon vesting upon a \"Change In Control\" of CytoSorbents Corporation (the \"Company\") as defined in the Amended and Restated CytoSorbents Corporation 2014 Long-Term Incentive Plan: (a) 55,000 RSUs granted on April 8, 2015, (b) 5,000 RSUs granted on June 7, 2016, (c) 6,000 RSUs granted on February 24, 2017 and (d) 3,300 RSUs granted on March 15, 2018; and (ii) 60,746 shares of common stock owned by the reporting person, inclusive of the 5,000 shares of common stock purchased in the open market and reported on this Form 4."}],"balance_after":130046,"source":{"system":"sec-edgar","filing":"0001104659-22-057514","document":"tm2214932-1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175151/000110465922057514/tm2214932-1_4.xml","form_type":"4"}},{"id":2582059,"issuer":{"id":7625,"kind":"organization","name":"Cytosorbents Corp","symbol":"CTSO"},"owners":[{"id":117149,"kind":"person","name":"Kraus Al","position":1,"cik":"0001368152","reported_name":"Kraus Al","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-09-02T20:31:46.000Z","date":"2021-08-31","kind":"exercise","acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":4.125,"exercise_date":"2012-01-18","expiration_date":"2022-01-18","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001104659-21-112499","document":"tm2126875-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1175151/000110465921112499/tm2126875-1_4seq1.xml","form_type":"4"}},{"id":2582058,"issuer":{"id":7625,"kind":"organization","name":"Cytosorbents Corp","symbol":"CTSO"},"owners":[{"id":117149,"kind":"person","name":"Kraus Al","position":1,"cik":"0001368152","reported_name":"Kraus Al","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-02T20:31:46.000Z","date":"2021-08-31","kind":"sale","acquired":false,"shares":4000,"price":9.3978,"value":37591.2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the weighted average price of sales on August 31, 2021. The shares were sold in multiple transactions at prices ranging from $9.38 to $9.409, inclusive. The reporting person undertakes to provide to CytoSorbents Corporation (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes: (i) the following RSUs that will be settled into common stock upon vesting upon a \"Change In Control\" of the Company as defined in the Amended and Restated CytoSorbents Corporation 2014 Long-Term Incentive Plan: (a) 55,000 RSUs granted on April 8, 2015, (b) 5,000 RSUs granted on June 7, 2016, (c) 6,000 RSUs granted on February 24, 2017 and (d) 3,300 RSUs granted on March 15, 2018; and (ii) 55,746 shares of common stock owned by the reporting person."}],"balance_after":125046,"source":{"system":"sec-edgar","filing":"0001104659-21-112499","document":"tm2126875-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1175151/000110465921112499/tm2126875-1_4seq1.xml","form_type":"4"}},{"id":2582057,"issuer":{"id":7625,"kind":"organization","name":"Cytosorbents Corp","symbol":"CTSO"},"owners":[{"id":117149,"kind":"person","name":"Kraus Al","position":1,"cik":"0001368152","reported_name":"Kraus Al","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-02T20:31:46.000Z","date":"2021-08-31","kind":"exercise","acquired":true,"shares":4000,"price":4.125,"value":16500.0,"ownership":{"direct":true},"balance_after":129046,"source":{"system":"sec-edgar","filing":"0001104659-21-112499","document":"tm2126875-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175151/000110465921112499/tm2126875-1_4seq1.xml","form_type":"4"}},{"id":2749696,"issuer":{"id":7625,"kind":"organization","name":"Cytosorbents Corp","symbol":"CTSO"},"owners":[{"id":117149,"kind":"person","name":"Kraus Al","position":1,"cik":"0001368152","reported_name":"Kraus Al","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-04-15T01:16:04.000Z","date":"2021-04-12","kind":"grant","acquired":true,"shares":34500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options were granted pursuant to the Amended and Restated CytoSorbents Corporation 2014 Long-Term Incentive Plan. The shares underlying the stock options will vest in four equal parts on 4/12/2021, 6/30/2021, 9/30/2021 and 12/31/2021, subject to the reporting person's continued service as of the applicable vesting date."}],"balance_after":34500,"derivative":{"exercise_price":8.99,"expiration_date":"2031-04-12","underlying":"Common Stock","underlying_shares":34500},"source":{"system":"sec-edgar","filing":"0001104659-21-050401","document":"tm2113016d7_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175151/000110465921050401/tm2113016d7_4.xml","form_type":"4"}},{"id":2984176,"issuer":{"id":7625,"kind":"organization","name":"Cytosorbents Corp","symbol":"CTSO"},"owners":[{"id":117149,"kind":"person","name":"Kraus Al","position":1,"cik":"0001368152","reported_name":"Kraus Al","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-11-12T22:31:26.000Z","date":"2020-11-10","kind":"exercise","acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options were originally granted to Mr. Kraus on January 6, 2011 as compensation for services rendered. The grant became fully vested on January 6, 2020."}],"balance_after":0,"derivative":{"exercise_price":3.45,"expiration_date":"2021-01-06","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001104659-20-124504","document":"tm2035834-1_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1175151/000110465920124504/tm2035834-1_4.xml","form_type":"4"}},{"id":2984175,"issuer":{"id":7625,"kind":"organization","name":"Cytosorbents Corp","symbol":"CTSO"},"owners":[{"id":117149,"kind":"person","name":"Kraus Al","position":1,"cik":"0001368152","reported_name":"Kraus Al","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-11-12T22:31:26.000Z","date":"2020-11-10","kind":"sale","acquired":false,"shares":8000,"price":8,"value":64000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were sold in multiple transactions and multiple lots for the same price for this sale have been combined."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes: (i) the following RSUs that will be settled into common stock upon vesting upon a \"Change In Control\" of CytoSorbents Corporation (the \"Company\") as defined in the Amended and Restated CytoSorbents Corporation 2014 Long-Term Incentive Plan: (a) 55,000 RSUs granted on April 8, 2015, (b) 5,000 RSUs granted on June 7, 2016, (c) 6,000 RSUs granted on February 24, 2017 and (d) 3,300 RSUs granted on March 15, 2018; and (ii) 55,746 shares of common stock owned by the reporting person."}],"balance_after":125046,"source":{"system":"sec-edgar","filing":"0001104659-20-124504","document":"tm2035834-1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1175151/000110465920124504/tm2035834-1_4.xml","form_type":"4"}},{"id":2984174,"issuer":{"id":7625,"kind":"organization","name":"Cytosorbents Corp","symbol":"CTSO"},"owners":[{"id":117149,"kind":"person","name":"Kraus Al","position":1,"cik":"0001368152","reported_name":"Kraus Al","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-11-12T22:31:26.000Z","date":"2020-11-10","kind":"exercise","acquired":true,"shares":8000,"price":3.45,"value":27600.0,"ownership":{"direct":true},"balance_after":133046,"source":{"system":"sec-edgar","filing":"0001104659-20-124504","document":"tm2035834-1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175151/000110465920124504/tm2035834-1_4.xml","form_type":"4"}},{"id":3233284,"issuer":{"id":7625,"kind":"organization","name":"Cytosorbents Corp","symbol":"CTSO"},"owners":[{"id":117149,"kind":"person","name":"Kraus Al","position":1,"cik":"0001368152","reported_name":"Kraus Al","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-03-03T22:01:06.000Z","date":"2020-02-28","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Includes 30,000 stock options granted on 2/28/2020 and reported on this Form 4. These options were granted pursuant to the Amended and Restated CytoSorbents Corporation 2014 Long-Term Incentive Plan and will vest in four equal parts on 3/31/2020, 6/30/2020, 9/30/2020 and 12/31/2020."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 30,000 stock options granted on 2/28/2020 and reported on this Form 4. These options were granted pursuant to the Amended and Restated CytoSorbents Corporation 2014 Long-Term Incentive Plan and will vest in four equal parts on 3/31/2020, 6/30/2020, 9/30/2020 and 12/31/2020."}],"balance_after":30000,"derivative":{"exercise_price":6.03,"expiration_date":"2030-02-28","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001104659-20-028655","document":"tm2011575d7_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175151/000110465920028655/tm2011575d7_form4.xml","form_type":"4"}},{"id":3456859,"issuer":{"id":7625,"kind":"organization","name":"Cytosorbents Corp","symbol":"CTSO"},"owners":[{"id":117149,"kind":"person","name":"Kraus Al","position":1,"cik":"0001368152","reported_name":"Kraus Al","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-07-25T00:17:30.000Z","date":"2019-07-22","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Such options were granted pursuant to the Amended and Restated CytoSorbents Corporation 2014 Long-Term Incentive Plan and vest in four equal parts at the end of each calendar quarter.  The grant gives effect to vesting which was to occur on March 31, 2019 and June 30, 2019.  The remaining portion of the grant will vest on September 30, 2019 and December 31, 2019."}],"balance_after":30000,"derivative":{"exercise_price":7.33,"expiration_date":"2029-07-22","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001144204-19-035840","document":"tv525806_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175151/000114420419035840/tv525806_4.xml","form_type":"4"}},{"id":3828879,"issuer":{"id":7625,"kind":"organization","name":"Cytosorbents Corp","symbol":"CTSO"},"owners":[{"id":117149,"kind":"person","name":"Kraus Al","position":1,"cik":"0001368152","reported_name":"Kraus Al","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-09-01T00:19:33.000Z","date":"2018-08-30","kind":"exercise","acquired":false,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options issued to the reporting person became exercisable according to the following vesting schedule: 4,500 stock options vested on 1/28/2009; 4,500 stock options vested on 1/28/2010; 4,500 stock options vested on 1/28/2011; and 4,500 stock options vested on 1/28/2012."}],"balance_after":0,"derivative":{"exercise_price":4.2,"expiration_date":"2019-01-28","underlying":"Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001144204-18-047656","document":"tv502207_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1175151/000114420418047656/tv502207_4.xml","form_type":"4"}},{"id":3828878,"issuer":{"id":7625,"kind":"organization","name":"Cytosorbents Corp","symbol":"CTSO"},"owners":[{"id":117149,"kind":"person","name":"Kraus Al","position":1,"cik":"0001368152","reported_name":"Kraus Al","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-09-01T00:19:33.000Z","date":"2018-08-30","kind":"exercise","acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":2.1,"exercise_date":"2009-01-08","expiration_date":"2019-01-08","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001144204-18-047656","document":"tv502207_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1175151/000114420418047656/tv502207_4.xml","form_type":"4"}},{"id":3828877,"issuer":{"id":7625,"kind":"organization","name":"Cytosorbents Corp","symbol":"CTSO"},"owners":[{"id":117149,"kind":"person","name":"Kraus Al","position":1,"cik":"0001368152","reported_name":"Kraus Al","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-09-01T00:19:33.000Z","date":"2018-08-30","kind":"sale","acquired":false,"shares":26000,"price":14.4724,"value":376282.4,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.45 to $14.605. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes (a) the following restricted stock units subject to vesting upon a \"Change in Control\" of CytoSorbents Corporation (the \"Company\"), as defined in the CytoSorbents Corporation 2014 Long-Term Incentive Plan: (i) 3,300 restricted stock units granted on March 15, 2018, (ii) 6,000 restricted stock units granted on February 24, 2017, (iii) 5,000 restricted stock units granted on June 7, 2016, and (iv) 55,000 restricted stock units granted on April 8, 2015, and (b) 55,746 shares of common stock owned by the reporting person."}],"balance_after":125046,"source":{"system":"sec-edgar","filing":"0001144204-18-047656","document":"tv502207_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1175151/000114420418047656/tv502207_4.xml","form_type":"4"}},{"id":3828876,"issuer":{"id":7625,"kind":"organization","name":"Cytosorbents Corp","symbol":"CTSO"},"owners":[{"id":117149,"kind":"person","name":"Kraus Al","position":1,"cik":"0001368152","reported_name":"Kraus Al","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-09-01T00:19:33.000Z","date":"2018-08-30","kind":"exercise","acquired":true,"shares":18000,"price":4.2,"value":75600.0,"ownership":{"direct":true},"balance_after":151046,"source":{"system":"sec-edgar","filing":"0001144204-18-047656","document":"tv502207_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1175151/000114420418047656/tv502207_4.xml","form_type":"4"}},{"id":3828875,"issuer":{"id":7625,"kind":"organization","name":"Cytosorbents Corp","symbol":"CTSO"},"owners":[{"id":117149,"kind":"person","name":"Kraus Al","position":1,"cik":"0001368152","reported_name":"Kraus Al","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-09-01T00:19:33.000Z","date":"2018-08-30","kind":"exercise","acquired":true,"shares":8000,"price":2.1,"value":16800.0,"ownership":{"direct":true},"balance_after":133046,"source":{"system":"sec-edgar","filing":"0001144204-18-047656","document":"tv502207_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175151/000114420418047656/tv502207_4.xml","form_type":"4"}},{"id":3955101,"issuer":{"id":7625,"kind":"organization","name":"Cytosorbents Corp","symbol":"CTSO"},"owners":[{"id":117149,"kind":"person","name":"Kraus Al","position":1,"cik":"0001368152","reported_name":"Kraus Al","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-04-27T15:45:10.000Z","date":"2018-03-15","kind":"grant","acquired":true,"shares":28875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Such options were granted pursuant to the Plan and vest in four equal parts at the end of each calendar quarter beginning January 1, 2018."}],"balance_after":28875,"derivative":{"exercise_price":7.9,"expiration_date":"2028-03-15","underlying":"Common Stock","underlying_shares":28875},"source":{"system":"sec-edgar","filing":"0001144204-18-022972","document":"tv492279_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1175151/000114420418022972/tv492279_4.xml","form_type":"4"}},{"id":3955100,"issuer":{"id":7625,"kind":"organization","name":"Cytosorbents Corp","symbol":"CTSO"},"owners":[{"id":117149,"kind":"person","name":"Kraus Al","position":1,"cik":"0001368152","reported_name":"Kraus Al","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-04-27T15:45:10.000Z","date":"2018-03-15","kind":"grant","acquired":true,"shares":3300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units and will be settled into common stock upon vesting upon a \"Change in Control\" of CytoSorbents Corporation, as defined in the CytoSorbents Corporation 2014 Long-Term Incentive Plan (the \"Plan\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes (a) the following restricted stock units subject to vesting in accordance with the schedule set forth in (1) above: (i) 3,300 restricted stock units granted on March 15, 2018 and reported on this Form 4, (ii) 6,000 restricted stock units granted on February 24, 2017, (iii) 5,000 restricted stock units granted on June 7, 2016, and (iv) 55,000 restricted stock units granted on April 8, 2015, and (b) 55,746 shares of common stock owned by the reporting person."}],"balance_after":125046,"source":{"system":"sec-edgar","filing":"0001144204-18-022972","document":"tv492279_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175151/000114420418022972/tv492279_4.xml","form_type":"4"}},{"id":4418081,"issuer":{"id":7625,"kind":"organization","name":"Cytosorbents Corp","symbol":"CTSO"},"owners":[{"id":117149,"kind":"person","name":"Kraus Al","position":1,"cik":"0001368152","reported_name":"Kraus Al","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-02-28T22:14:45.000Z","date":"2017-02-24","kind":"grant","acquired":true,"shares":27500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Such options were granted pursuant to the CytoSorbents Corporation 2014 Long-Term Incentive Plan, which vest in four equal parts at the end of each calendar quarter beginning April 1, 2017."}],"balance_after":27500,"derivative":{"exercise_price":5.6,"expiration_date":"2027-02-24","underlying":"Common Stock","underlying_shares":27500},"source":{"system":"sec-edgar","filing":"0001144204-17-011817","document":"v460704_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1175151/000114420417011817/v460704_4.xml","form_type":"4"}},{"id":4418080,"issuer":{"id":7625,"kind":"organization","name":"Cytosorbents Corp","symbol":"CTSO"},"owners":[{"id":117149,"kind":"person","name":"Kraus Al","position":1,"cik":"0001368152","reported_name":"Kraus Al","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-02-28T22:14:45.000Z","date":"2017-02-24","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units and will be settled into common stock upon vesting upon a \"Change In Control\" of CytoSorbents Corporation, as defined in the CytoSorbents Corporation 2014 Long-Term Incentive Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes (i) 6,000 restricted stock units granted on February 24, 2017 and reported on this Form 4, (ii) 5,000 restricted stock units granted on June 7, 2016, subject to vesting in accordance with the schedule set forth in (1) above, (iii) 55,000 restricted stock units granted on April 8, 2015, subject to vesting in accordance with the schedule set forth in (1) above and (iv) 55,746 shares of common stock owned by the reporting person."}],"balance_after":121746,"source":{"system":"sec-edgar","filing":"0001144204-17-011817","document":"v460704_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175151/000114420417011817/v460704_4.xml","form_type":"4"}}]}